In this single center trial of 364 adults with normal-EF CHF, they were randomized to 3 groups for 2 years: usual care, NT-proBNP-guided care, or intensive clinical assessment-guided care. 1 year mortality was less in the BNP and clinical management groups (9%) than the usual care group (19%). 3 year mortality was less in the BNP group (16%) than the other 2 groups (31%), but only patients <75 years old. BNP guided therapy does not alter short term mortality compared to intensive clinical management. More studies are needed to determine if BNP guided therapy is beneficial, and in what subgroups, but should not currently drive clinical management (abstract).
What comes to mind when you think of getting CME? I bet most of you would say sitting in an auditorium, whether that be during your local grand rounds or at our professional society meeting, like Hospital Medicine 16 in sunny San Diego this past March. Hanging out in the Twitterverse? Probably not so much… […]
As a nurse practitioner in hospital medicine I have multiple opportunities to interact with all sorts of physician hospitalist colleagues, hospital medicine group leaders, quality officers etc. Often their interactions with me take on a certain wary curiosity, like I am some exotic monkey or another creature that is unfamiliar to them. If I am […]
By reading the headlines recently, practitioners would not know if they saved or tanked the healthcare system. One day disaster looms, the next we have moderated growth and business can continue as usual (and by business, I mean doing the correct things correctly). A new study, along with some recent data, helps shed some light […]